Kelly Mousa

2.0k citations
24 papers · 285 indexed · h-index 9
Topics
Cancer Treatment and Pharmacology (6 papers)Renal cell carcinoma treatment (5 papers)Bladder and Urothelial Cancer Treatments (5 papers)

In The Last Decade

Kelly Mousa

23 papers receiving 284 citations

Peers

Kelly Mousa
Comparison fields: 5 of 29
  • Pulmonary and Respiratory Medicine 149
  • Oncology 135
  • Molecular Biology 125
  • Surgery 99
  • Cancer Research 85
Replace J. Samuel with:
J. Samuel United Kingdom
Victoria Hinder New Zealand
Benjamin Miron United States
Akhila Wimalasingham United Kingdom
Yucai Wu China
Xiaoliang Zhu China
Konstantin Penkov United States
Shanti Ross United States
Colleen Watt United States
Natalie Q. Wang Canada
Kelly Mousa relative to J. Samuel United Kingdom J. Samuel's profile →
Citations per field
00.5×10×20×28.5×
J. Samuel · 1×
Citations per year

Countries citing papers authored by Kelly Mousa

Since Specialization
Citations

This map shows the geographic impact of Kelly Mousa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Mousa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Mousa more than expected).

Fields of papers citing papers by Kelly Mousa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Mousa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Mousa. The network helps show where Kelly Mousa may publish in the future.

Co-authorship network of co-authors of Kelly Mousa

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Mousa. A scholar is included among the top collaborators of Kelly Mousa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Mousa. Kelly Mousa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 35
2 0
3 2
4 1
5 19
6 1
7 12
8 6
9 3
10 13
11 3
12 9
13 41
14 3
15 12
16 4
17 1
18 3
19 1
20 3

About Kelly Mousa

Kelly Mousa is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 24 papers that have together received 285 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Renal cell carcinoma treatment (5 papers) and Bladder and Urothelial Cancer Treatments (5 papers). The work is most often cited by research in Cancer Research (85 citations), Oncology (135 citations) and Pulmonary and Respiratory Medicine (149 citations). Kelly Mousa has collaborated with scholars based in United Kingdom, Spain and Germany. Frequent co-authors include Aaron Prendergast, Alejo Rodríguez‐Vida, Cristina Suárez, María José Méndez-Vidal, Shah‐Jalal Sarker, Christy Ralph, Hilary Glen, Fiona Thistlethwaite, Gopalakrishnan Srinivasan and James Larkin. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026